Renewed agreement continues Adeia’s media IP license with one of the world’s largest television and consumer electronics manufacturers

SAN JOSE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA), the technology company pioneering foundational innovations that shape how the world computes, connects and experiences entertainment, today announced that TCL Electronics Holdings Limited (“TCL”), a global leader in consumer electronics and one of the world’s largest television manufacturers headquartered in Shenzhen, China, has entered into a multi-year license renewal with Adeia for access to its media intellectual property (IP) portfolio.

This renewal underscores the strength of Adeia’s licensing relationships with leading consumer electronics manufacturers globally as they navigate an evolving media technology landscape.

“We’re pleased to continue our relationship with TCL,” said Dr. Mark Kokes, chief revenue officer of Adeia. “This renewal reflects the continued relevance of our media portfolio as smart TVs become increasingly important platforms for streaming, content discovery, personalization, advertising and connected consumer experiences.”

Adeia continues to invest in and expand its media IP portfolio, which has been developed through decades of research and development. This growing portfolio underpins content discovery, personalization, and streaming capabilities for consumer electronics manufacturers worldwide.

About Adeia

Adeia Inc. (Nasdaq: ADEA) develops foundational innovations that shape how the world computes, connects and experiences entertainment. Its inventions span a broad range of semiconductor and media technologies, including 3D interconnect (hybrid bonding) and advanced thermal management for AI datacenters, as well as content discovery, personalization, and streaming. These inventions are licensed to leaders across the chip design and manufacturing, consumer electronics, automotive, digital entertainment, and e-commerce industries. Adeia’s innovations enable more powerful and efficient products, and more immersive, personalized experiences across billions of devices worldwide. Learn more at www.adeia.com.

About TCL

Founded in 1981, TCL—short for “The Creative Life”—is dedicated to empowering smarter, healthier lifestyles through next-generation experiences. Operating through two independent entities, TCL Industries and TCL Technology, TCL delivers innovative solutions spanning TVs, smartphones, audio products, smart home devices, display technologies, and clean energy.

Today, with 50 R&D centers and 47 manufacturing bases globally, TCL operates in over 160 countries and regions, reinforcing its position as a globally competitive smart technology brand. To further inspire greatness, TCL has become an official Worldwide Olympic and Paralympic Partner in the Home Audiovisual Equipment and Home Appliances category. Learn more at https://www.tcl.com/global/en

Contacts

Adeia Investor Relations
Chris Chaney 
IR@adeia.com

Adeia Media Relations
Anna Enerio 
marketing@adeia.com

MONDOVI, Wis., Oct. 22, 2026 (GLOBE NEWSWIRE) — Marten Transport, Ltd. (Nasdaq/GS:MRTN) today reported a 30.7% improvement in net income to $2.9 million, or 4 cents per diluted share, for the third quarter ended September 30, 2026, from $2.2 million, or 3 cents per diluted share, for the third quarter of 2025. For the nine-month period ended September 30, 2026, net income was $9.6 million, or 12 cents per diluted share, compared with $13.7 million, or 17 cents per diluted share, for the 2025 nine-month period.

Operating revenue was $223.2 million for the third quarter of 2026 compared with $220.5 million for the third quarter of 2025. Our intermodal operations, which were sold in 2025, had operating revenue of $9.9 million in the 2025 quarter. Excluding fuel surcharges, operating revenue was $184.2 million for the 2026 quarter compared with $194.0 million for the 2025 quarter. Fuel surcharge revenue increased to $39.0 million for the 2026 quarter from $26.5 million for the 2025 quarter.

Operating revenue was $650.3 million for the first nine months of 2026 compared with $673.5 million for the first nine months of 2025. Our intermodal operations had operating revenue of $33.7 million in the first nine months of 2025. Excluding fuel surcharges, operating revenue was $546.6 million for the 2026 period compared with $593.5 million for the 2025 period. Fuel surcharge revenue increased to $103.7 million for the 2026 period from $80.0 million for the 2025 period.

Operating income improved 11.9% to $3.1 million for the third quarter of 2026 from $2.7 million for the third quarter of 2025.

Operating income was $11.6 million for the first nine months of 2026 compared with $18.3 million for the first nine months of 2025.

Operating expenses as a percentage of operating revenue improved to 98.6% for the 2026 quarter from 98.8% for the 2025 quarter. Operating expenses as a percentage of operating revenue, with both amounts net of fuel surcharges, improved to 98.3% for the 2026 quarter from 98.6% for the 2025 quarter.

Operating expenses as a percentage of operating revenue were 98.2% for the first nine months of 2026 and 97.3% for the first nine months of 2025. Operating expenses as a percentage of operating revenue, with both amounts net of fuel surcharges, were 97.9% for the 2026 period and 96.9% for the 2025 period.

Chairman of the Board and Chief Executive Officer Randolph L. Marten stated, “The truckload freight market has sharply tightened since earlier this year as renewed and enhanced enforcement of federal and state law is removing a meaningful amount of noncompliant and unqualified driver capacity from the marketplace. We are securing higher pricing from our customers for our premium services while enhancing freight quality across our network within these early stages of the freight market upcycle. Our Truckload average rate per total mile, net of fuel surcharges, increased 14.1% over the third quarter of 2025.”

“Despite these positive trends, our earnings were negatively affected by unusually high net fuel and health insurance costs. Relative to our average quarterly levels during the first half of the year, net fuel increased by $3.5 million and health insurance, within salaries, wages and benefits, increased by $2.0 million in the third quarter. Over the same period, the increase in our rate of driver pay negatively impacted results by $1.0 million, while a larger gain on sale of revenue equipment provided a $1.5 million benefit. Collectively, these factors reduced our third quarter net income by $3.7 million, or 4.5 cents per share.”

“We are focused on mitigating the impact of the recent rise in diesel fuel prices to record levels through disciplined fuel expense and fuel surcharge management initiatives. The margin pressure results primarily from the timing lag inherent in truckload industry fuel surcharge programs relative to rapidly rising diesel fuel costs, as well as the higher fuel consumption associated with our temperature-controlled operations.”

“As we continue through our 80th year, our priorities remain unchanged: delivering safe, premium service, driving operating efficiencies through data and technology, and maintaining rigorous cost discipline. Our strong, debt-free balance sheet provides the financial flexibility to continue investing in our technology and modern fleet, while positioning the Company to capitalize on attractive opportunities for profitable organic growth.”

Current Investor Presentation

Marten Transport, with headquarters in Mondovi, Wis., is a multifaceted business offering a network of time and temperature-sensitive and dry truck-based transportation and distribution capabilities across Marten’s five distinct business platforms – Temperature-Sensitive and Dry Truckload, Dedicated, Brokerage and MRTN de Mexico. Marten’s Intermodal operations were sold effective September 30, 2025. Marten is one of the leading temperature-sensitive truckload carriers in the United States, specializing in transporting and distributing food, beverages and other consumer packaged goods that require a temperature-controlled or insulated environment. The Company offers service in the United States, Mexico and Canada, concentrating on expedited movements for high-volume customers. Marten’s common stock is traded on the Nasdaq Global Select Market under the symbol MRTN.

This press release contains certain statements that may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include a discussion of Marten’s prospects for future growth, including the impact on the freight market of renewed and enhanced enforcement of federal and state law that is removing a meaningful amount of noncompliant and unqualified driver capacity from the marketplace, and by their nature involve substantial risks and uncertainties, and actual results may differ materially from those expressed in such forward-looking statements. Important factors known to the Company that could cause actual results to differ materially from those discussed in the forward-looking statements are discussed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and in Part II, Item 1A of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. The Company undertakes no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACTS: Randy Marten, Chairman of the Board and Chief Executive Officer, Doug Petit, President, and Jim Hinnendael, Executive Vice President and Chief Financial Officer, of Marten Transport, Ltd., 715-926-4216.

           
MARTEN TRANSPORT, LTD.
CONSOLIDATED CONDENSED BALANCE SHEETS
 
           
  September 30,     December 31,  
(In thousands, except share information) 2026     2025  
  (Unaudited)          
ASSETS              
Current assets:              
Cash and cash equivalents $ 91,503     $ 43,278  
Escrow deposit   5,000       5,000  
Receivables:              
Trade, net   96,911       85,807  
Other   8,403       13,084  
Prepaid expenses and other   22,574       24,532  
Total current assets   224,391       171,701  
               
Property and equipment:              
Revenue equipment, buildings and land, office equipment and other   1,086,781       1,128,932  
Accumulated depreciation   (356,617 )     (352,426 )
Net property and equipment   730,164       776,506  
Other noncurrent assets   1,411       1,560  
Total assets $ 955,966     $ 949,767  
               
LIABILITIES AND STOCKHOLDERS’ EQUITY              
Current liabilities:              
Accounts payable $ 35,784     $ 28,769  
Insurance and claims accruals   42,620       43,700  
Accrued and other current liabilities   23,038       19,763  
Total current liabilities   101,442       92,232  
Deferred income taxes   90,278       89,716  
Noncurrent operating lease liabilities   82       194  
Total liabilities   191,802       182,142  
               
Stockholders’ equity:              
Preferred stock, $.01 par value per share; 2,000,000 shares authorized; no shares issued and outstanding   –       –  
Common stock, $.01 par value per share; 192,000,000 shares authorized; 81,661,669 shares at September 30, 2026, and 81,542,174 shares at December 31, 2025, issued and outstanding   817       815  
Additional paid-in capital   56,364       54,762  
Retained earnings   706,983       712,048  
Total stockholders’ equity   764,164       767,625  
Total liabilities and stockholders’ equity $ 955,966     $ 949,767  
               

MARTEN TRANSPORT, LTD.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
 
           
  Three Months     Nine Months  
  Ended September 30,     Ended September 30,  
(In thousands, except per share information) 2026     2025     2026     2025  
                               
Operating revenue $ 223,231     $ 220,470     $ 650,300     $ 673,544  
                               
Operating expenses (income):                              
Salaries, wages and benefits   72,970       78,972       217,627       236,342  
Purchased transportation   37,917       42,284       110,204       123,063  
Fuel and fuel taxes   49,302       33,526       128,976       99,234  
Supplies and maintenance   15,639       15,585       46,085       46,704  
Depreciation   24,458       25,447       74,226       80,224  
Operating taxes and licenses   2,252       2,423       6,770       7,291  
Insurance and claims   11,153       11,382       33,704       40,611  
Communications and utilities   2,118       2,093       6,375       6,536  
Gain on disposition of revenue equipment   (3,027 )     (1,903 )     (6,120 )     (8,750 )
Other   7,385       7,923       20,881       23,958  
                               
Total operating expenses   220,167       217,732       638,728       655,213  
                               
Operating income   3,064       2,738       11,572       18,331  
                               
Other   (882 )     (213 )     (2,060 )     (998 )
                               
Income before income taxes   3,946       2,951       13,632       19,329  
                               
Income taxes expense   1,037       725       4,002       5,582  
                               
Net income $ 2,909     $ 2,226     $ 9,630     $ 13,747  
                               
Basic earnings per common share $ 0.04     $ 0.03     $ 0.12     $ 0.17  
                               
Diluted earnings per common share $ 0.04     $ 0.03     $ 0.12     $ 0.17  
                               
Dividends declared per common share $ 0.06     $ 0.06     $ 0.18     $ 0.18  
                               

MARTEN TRANSPORT, LTD.
SEGMENT INFORMATION
(Unaudited)
 
                           
                  Dollar     Percentage  
                  Change     Change  
  Three Months     Three Months     Three Months  
  Ended     Ended     Ended  
  September 30,     September 30,     September 30,  
(Dollars in thousands) 2026     2025     2026 vs. 2025     2026 vs. 2025  
Operating revenue:                              
Truckload revenue, net of fuel surcharge revenue $ 94,053     $ 90,138     $ 3,915       4.3 %
Truckload fuel surcharge revenue   23,251       14,691       8,560       58.3  
Total Truckload revenue   117,304       104,829       12,475       11.9  
                               
Dedicated revenue, net of fuel surcharge revenue   51,442       56,675       (5,233 )     (9.2 )
Dedicated fuel surcharge revenue   15,748       10,335       5,413       52.4  
Total Dedicated revenue   67,190       67,010       180       0.3  
                               
Brokerage revenue   38,737       38,780       (43 )     (0.1 )
                               
Intermodal revenue, net of fuel surcharge revenue   –       8,369       (8,369 )     (100.0 )
Intermodal fuel surcharge revenue   –       1,482       (1,482 )     (100.0 )
Total Intermodal revenue   –       9,851       (9,851 )     (100.0 )
                               
Total operating revenue $ 223,231     $ 220,470     $ 2,761       1.3 %
                               
Operating income/(loss):                              
Truckload $ (192 )   $ (2,002 )   $ 1,810       90.4 %
Dedicated   1,248       3,426       (2,178 )     (63.6 )
Brokerage   2,008       1,607       401       25.0  
Intermodal   –       (293 )     293       100.0  
Total operating income $ 3,064     $ 2,738     $ 326       11.9 %
                               
Operating ratio:                              
Truckload   100.2 %     101.9 %                
Dedicated   98.1       94.9                  
Brokerage   94.8       95.9                  
Intermodal   –       103.0                  
Consolidated operating ratio   98.6 %     98.8 %                
                               
Operating ratio, net of fuel surcharges:                              
Truckload   100.2 %     102.2 %                
Dedicated   97.6       94.0                  
Brokerage   94.8       95.9                  
Intermodal   –       103.5                  
Consolidated operating ratio, net of fuel surcharges   98.3 %     98.6 %                
                               

MARTEN TRANSPORT, LTD.
SEGMENT INFORMATION
(Unaudited)
 
                           
                  Dollar     Percentage  
                  Change     Change  
  Nine Months     Nine Months     Nine Months  
  Ended     Ended     Ended  
  September 30,     September 30,     September 30,  
(Dollars in thousands) 2026     2025     2026 vs. 2025     2026 vs. 2025  
Operating revenue:                              
Truckload revenue, net of fuel surcharge revenue $ 276,084     $ 272,728     $ 3,356       1.2 %
Truckload fuel surcharge revenue   62,930       42,978       19,952       46.4  
Total Truckload revenue   339,014       315,706       23,308       7.4  
                               
Dedicated revenue, net of fuel surcharge revenue   157,194       180,418       (23,224 )     (12.9 )
Dedicated fuel surcharge revenue   40,755       32,091       8,664       27.0  
Total Dedicated revenue   197,949       212,509       (14,560 )     (6.9 )
                               
Brokerage revenue   113,337       111,658       1,679       1.5  
                               
Intermodal revenue, net of fuel surcharge revenue   –       28,730       (28,730 )     (100.0 )
Intermodal fuel surcharge revenue   –       4,941       (4,941 )     (100.0 )
Total Intermodal revenue   –       33,671       (33,671 )     (100.0 )
                               
Total operating revenue $ 650,300     $ 673,544     $ (23,244 )     (3.5 )%
                               
Operating income/(loss):                              
Truckload $ 1,281     $ 42     $ 1,239       2,950.0 %
Dedicated   5,310       13,709       (8,399 )     (61.3 )
Brokerage   4,981       6,463       (1,482 )     (22.9 )
Intermodal   –       (1,883 )     1,883       100.0  
Total operating income $ 11,572     $ 18,331     $ (6,759 )     (36.9 )%
                               
Operating ratio:                              
Truckload   99.6 %     100.0 %                
Dedicated   97.3       93.5                  
Brokerage   95.6       94.2                  
Intermodal   –       105.6                  
Consolidated operating ratio   98.2 %     97.3 %                
                               
Operating ratio, net of fuel surcharges:                              
Truckload   99.5 %     100.0 %                
Dedicated   96.6       92.4                  
Brokerage   95.6       94.2                  
Intermodal   –       106.6                  
Consolidated operating ratio, net of fuel surcharges   97.9 %     96.9 %                
                               

MARTEN TRANSPORT, LTD.
OPERATING STATISTICS
(Unaudited)
 
           
  Three Months     Nine Months  
  Ended September 30,     Ended September 30,  
  2026     2025     2026     2025  
Truckload Segment:                              
Revenue (in thousands) $ 117,304     $ 104,829     $ 339,014     $ 315,706  
Average revenue, net of fuel surcharges, per tractor per week(1) $ 4,749     $ 4,129     $ 4,588     $ 4,178  
Average tractors(1)   1,507       1,661       1,543       1,674  
Average miles per trip   506       508       511       523  
Non-revenue miles percentage(2)   10.7 %     11.0 %     10.7 %     11.1 %
Total miles (in thousands)   34,825       38,081       108,587       115,575  
                               
Dedicated Segment:                              
Revenue (in thousands) $ 67,190     $ 67,010     $ 197,949     $ 212,509  
Average revenue, net of fuel surcharges, per tractor per week(1) $ 3,862     $ 3,776     $ 3,896     $ 3,811  
Average tractors(1)   1,013       1,142       1,035       1,214  
Average miles per trip   292       292       295       300  
Non-revenue miles percentage(2)   1.1 %     1.1 %     1.1 %     1.3 %
Total miles (in thousands)   21,559       23,206       65,960       73,574  
                               
Brokerage Segment:                              
Revenue (in thousands) $ 38,737     $ 38,780     $ 113,337     $ 111,658  
Loads   22,141       25,940       70,613       70,450  
                               
Intermodal Segment:                              
Revenue (in thousands) $ –     $ 9,851     $ –     $ 33,671  
Loads   –       2,956       –       10,168  
Average tractors   –       61       –       72  
                               
At September 30, 2026 and September 30, 2025:                              
Total tractors(1)   2,501       2,823                  
Average age of company tractors (in years)   2.5       2.2                  
Total trailers   5,065       5,165                  
Average age of company trailers (in years)   5.3       4.9                  
Ratio of trailers to tractors(1)   2.0       1.8                  
                               

  Three Months     Nine Months  
  Ended September 30,     Ended September 30,  
(In thousands) 2026     2025     2026     2025  
                               
Net cash provided by operating activities $ 22,567     $ 18,538     $ 83,285     $ 87,906  
Net cash provided by/(used for) investing activities   (30,144 )     5,786       (21,020 )     (35,742 )
Net cash used for financing activities   (4,900 )     (4,891 )     (14,040 )     (14,946 )
                               
Weighted average shares outstanding:                              
Basic   81,662       81,520       81,623       81,508  
Diluted   81,664       81,527       81,625       81,516  

(1) Includes tractors driven by both company-employed drivers and independent contractors. Independent contractors provided 77 and 83 tractors as of September 30, 2026 and 2025, respectively.
 
(2) Represents the percentage of miles for which the company is not compensated.
   

WALTHAM, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 16 newly hired employees. The awards were made as an inducement material to the newly hired employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement equity awards consisted of non-statutory stock options to purchase up to an aggregate of 290,100 shares of Dyne’s common stock at a per share exercise price equal to the closing price of Dyne’s common stock on The Nasdaq Global Select Market on October 20, 2026, and restricted stock units with respect to an aggregate of 92,300 shares of Dyne’s common stock. The stock options have a ten-year term and are scheduled to vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee’s start date and the remainder vesting in 12 equal quarterly installments thereafter, subject to such employee’s continued service to Dyne through the applicable vesting dates. The restricted stock units are scheduled to vest over four years from the applicable employee’s start date in four equal annual installments, subject to such employee’s continued service to Dyne through the applicable vesting dates.

The inducement equity awards are subject to the terms and conditions of award agreements covering the grants and Dyne’s 2024 Inducement Stock Incentive Plan.

About Dyne Therapeutics

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Contacts:
Investors
Mia Tobias
ir@dyne-tx.com
781-317-0353

Media
Stacy Nartker
media@dyne-tx.com 
781-317-1938

ATHENS, Greece, Oct. 22, 2026 (GLOBE NEWSWIRE) — Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) today announced that its board of directors has declared a cash dividend per share of $0.15 for the third quarter of 2026 ended September 30, 2026.

The cash dividend for the third quarter of 2026 will be paid on November 12, 2026, to common shareholders of record on November 3, 2026.

The Company has implemented a Dividend Reinvestment Plan (“DRIP”) whereby common shareholders can elect to have dividends reinvested directly into additional common shares issued by the Company. To participate in the DRIP for the third quarter of 2026, the election deadline is November 3, 2026. For additional information on the plan, including the forms needed to enroll, please visit the website of Computershare Trust Company, N.A., the Company’s transfer agent administering the DRIP, at: www.computershare.com/investor.

The information on www.computershare.com/investor is not incorporated by reference into this press release and should not be considered part of this press release.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any common shares or any other securities, nor will there be any sale of common shares or any other securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Capital Clean Energy Carriers Corp.

Capital Clean Energy Carriers Corp. (NASDAQ: CCEC), an international shipping company, is a leading platform of gas carriage solutions with a focus on energy transition. CCEC’s in-the-water fleet includes 21 high-specification vessels, including 15 latest-generation Liquefied Natural Gas Carriers (“LNG/Cs”), one legacy Neo-Panamax container vessel, two dual-fuel medium gas carriers (“MG/Cs”) and three Handy Liquefied CO2 Multi-Gas Carriers (“HMG/Cs”). In addition, CCEC’s under-construction fleet includes six additional latest-generation LNG/Cs, four MG/Cs, one HMG/C and one LNG dual-fuel bunkering vessel to be delivered between the first quarter of 2027 and the first quarter of 2029.

For more information about CCEC, please visit: www.capitalcleanenergycarriers.com

Forward-Looking Statements
The statements in this press release that are not historical facts may be forward-looking statements (as such term is defined in Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements involve risks and uncertainties that could cause the stated or forecasted results to be materially different from those anticipated. Unless required by law, we expressly disclaim any obligation to update or revise any of these forward-looking statements, whether because of future events, new information, a change in our views or expectations, to conform to actual results or otherwise. We assume no responsibility for the accuracy and completeness of the forward-looking statements. We make no prediction or statement about the performance of our common shares.

Contact Details:

Investor Relations / Media
Brian Gallagher
EVP Investor Relations
Tel. +44-(770) 368 4996
E-mail: b.gallagher@capitalmaritime.com

Nicolas Bornozis / Markella Kara
Capital Link, Inc. (New York)
Tel. +1-212-661-7566
E-mail: ccec@capitallink.com

GARDEN CITY, N.Y., Oct. 22, 2026 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will release its third quarter 2026 financial results before market open on Thursday, November 5, 2026. The Company will host a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time. The Company will also host an Investor Day on Tuesday, December 1, 2026, at the Nasdaq MarketSite in New York City.

Third Quarter 2026 Conference Call

Investors and analysts may access the live conference call by dialing 1-833-862-0366 (USA) or 1-412-634-6210 (International). In addition, a live webcast of the conference call will be accessible through the investor relations website here.

For those who cannot listen to the live broadcast, an audio replay of the webcast will be available on the Company’s investor relations website at https://lifetimebrands.gcs-web.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International) and entering access code 10212812. 

Investor Day

The Company will host an Investor Day on Tuesday, December 1, 2026, at the Nasdaq MarketSite in New York City, from 11:00 a.m. to 2:00 p.m. Eastern Time. Members of the Company’s senior leadership team will provide an overview of the business, followed by a panel discussion with the Company’s Division Presidents and a question-and-answer session. In-person attendees will also see product displays and demonstrations. Investors and analysts interested in attending in person should RSVP to LCUT@mzgroup.us.

About Lifetime Brands, Inc.

Lifetime Brands is a leading global designer, developer and marketer of a broad range of branded consumer products used in the home. The Company markets its products under well-known kitchenware brands, including Farberware®, KitchenAid®, Sabatier®, Amco Houseworks®, Chef’n®, Chicago™ Metallic, Copco®, Fred® & Friends, Houdini™, KitchenCraft®, Kamenstein®, La Cafetière®, MasterClass®, Misto®, Swing-A-Way®, Taylor® Kitchen, Rabbit®, and Dolly®; respected tableware and giftware brands, including Mikasa®, Pfaltzgraff®, Fitz and Floyd®, Empire Silver™, Gorham®, International® Silver, Towle® Silversmiths, Wallace®, Wilton Armetale®, V&A®, Royal Botanic Gardens Kew®, Year & Day®, Dolly®, Royal Leerdam®, and ONIS®; and valued home solutions brands, including BUILT NY®, S’well®, Taylor® Bath, Taylor® Kitchen, Taylor® Weather, Elements®, Planet Box®, and Dolly®. The Company also provides exclusive private label products to leading retailers worldwide.

The Company’s corporate website is www.lifetimebrands.com.

Contacts:

Lifetime Brands, Inc.
Laurence Winoker, Chief Financial Officer
516-203-3590
investor.relations@lifetimebrands.com

or

MZ North America
Shannon Devine
Main: 203-741-8811
LCUT@mzgroup.us

IRVING, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE) — Quest Resource Holding Corporation (Nasdaq: QRHC) (“Quest” or the “Company”), a national leader in environmental waste and recycling services, today announced that it will release results for its third quarter ended September 30, 2026, on Thursday, November 5, 2026, after market close.

Management will host a conference call that same day at 5:00 PM ET to review the Company’s financial results and business outlook. Investors interested in participating in the live call can dial 1-877-270-2148 or 1-412-371-6060 (International). Investors can also access the call online through a listen-only webcast on the investor relations section of Quest’s website at http://investors.qrhc.com/.

The webcast, which may include forward-looking information, will be archived on the Quest investor relations website for at least 90 days and a telephonic playback of the conference call will be available by calling 1-855-669-9658 or 1-412-317-0088 (International). The replay access code is 2229290. The telephonic playback will be available approximately three hours after the conference ends and will be available through November 12, 2026.

About Quest Resource Holding Corporation
Quest is a national provider of waste and recycling services that empower larger businesses to excel in achieving their environmental and sustainability goals and responsibilities. Quest delivers focused expertise across multiple industry sectors to build single-source, customer-specific solutions that generate quantifiable business and sustainability results. Addressing a wide variety of waste streams and recyclables, Quest provides information and data that tracks and reports the environmental results of Quest’s services, gives actionable data to improve business operations, and enables Quest’s customers to excel in their business and sustainability responsibilities. For more information, visit https://questrmg.com/.

Investor Relations Contact
Alpha IR Group
Nick Nelson or Chris Hodges
QRHC@alpha-ir.com
312-445-2870

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) — Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) announced today that it will release financial results after market close on Wednesday, November 18, 2026, for its fourth quarter and full year 2026. CCIF will host a conference call at 10:00 a.m. EST on Thursday, November 19, 2026, to discuss the results.

The conference call will be available via public webcast via a link on Carlyle Credit Income Fund’s website at www.carlylecreditincomefund.com and will also be available on the website soon after the call’s completion.

About Carlyle Credit Income Fund

Carlyle Credit Income Fund (NYSE: CCIF) is an externally managed closed-end fund focused on investing in primarily equity and junior debt tranches of collateralized loan obligations (“CLOs”). The CLOs are collateralized by a portfolio consisting primarily of U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. CCIF is externally managed by Carlyle Global Credit Investment Management L.L.C. (“CGCIM”), an SEC-registered investment adviser and wholly owned subsidiary of Carlyle. CCIF draws upon the significant scale and resources of Carlyle as one of the world’s largest CLO managers.

Web: www.carlylecreditincomefund.com 

About Carlyle   

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $485 billion of assets under management as of June 30, 2026, Carlyle’s purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 28 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and on LinkedIn at The Carlyle Group.

Contacts:

Investors: Media:
Joseph Castilla Max Berger
+1 (866) 277-8243
investorrelations@carlylecreditincomefund.com 
+1 (917) 533-4374
Max.Berger@carlyle.com 

Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia

Highlights

  • Collaboration aims to accelerate precision oncology research in Australia
  • Combines Fortrea’s experience in oncology clinical trials with Omico’s Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program
  • Together, Fortrea and Omico offer more efficient investigator site selection and faster patient access by connecting patients with relevant biomarker-driven clinical trials

DURHAM, N.C. and SYDNEY, Oct. 22, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), and Omico, Australia’s leading precision oncology screening and trial matching organization, today announced a collaboration to accelerate precision oncology research by helping connect cancer patients to biomarker-matched clinical trials. By combining Omico’s precision oncology network with Fortrea’s scientific and clinical trial experience, the joint effort aims to improve study planning, site selection and patient recruitment to expand access to biomarker-driven oncology research globally.

Through this initiative, Omico will support Fortrea’s clients in their oncology drug development needs by providing access to patient population insights, including genomic profiling, trial-matching capabilities, real-world oncology data and patient referral pathways in Australia, a key country both for early and late phase Oncology clinical research activities. The collaboration will combine Fortrea’s oncology drug development experience with Omico’s flagship Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program, the largest cancer genomics initiative in Australia. PrOSPeCT is designed to provide molecular profiling and help match patients to biomarker-driven clinical trials and targeted therapies.

“Our collaboration with Omico is about seeking to reach the right patient for the right study as quickly as possible,” said Oren Cohen, M.D., Chief Medical Officer at Fortrea. “Modern oncology development demands ever-greater precision to match specific cancers with the therapies most likely to benefit patients, and to do so as quickly as possible. Our work with Omico accelerates our ability to identify the right patients for biomarker-driven studies in Australia and help advance precision medicine for people with cancer.”

Omico has built one of Australia’s most extensive precision oncology ecosystems, combining molecular profiling, real-world evidence, cohort research programs and a nationwide network of investigators and clinical sites. Omico has reported more than 23,000 consented patients within its clinic-genomic databases and has received referrals from more than 1,600 clinicians across Australia.

“Australia is well positioned to support global biomarker-driven clinical trials, through Omico’s established national precision oncology research infrastructure, expertise and networks,” said Professor David Thomas, Chief Science and Strategy Officer at Omico. “By combining our national data and trial matching capabilities with Fortrea’s global clinical development expertise, we can help international sponsors identify relevant patient populations, plan trials more effectively and support targeted recruitment.”

Fortrea’s oncology expertise is underpinned by thousands of operational professionals and supported by more than 50 oncology physicians on staff. This collaboration comes at a time when modern oncology drug development has accelerated the focus on precision medicine, biomarker-driven development and targeted patient identification. Working together, Fortrea and Omico can offer more efficient site selection and the ability to match patients with appropriate studies tied to their unique genomic data, enabling more people to participate in studies tailored to their specific condition in Australia.

About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn and X and Bluesky.

About Omico
Omico is an independent, national, not-for-profit research organisation changing the way we fight cancer. We work to improve outcomes for Australians with cancer by providing equitable access to precision oncology and translating scientific advances into clinical care and research, and generating the evidence needed to inform health policy and system reform. Working with Australia’s leading cancer institutes, researchers, clinicians, industry partners, advocacy groups and government, we are accelerating molecular profiling, biomarker-led clinical trials, personalised cancer risk management and real-world evidence.

About PrOSPeCT
PrOSPeCT is Australia’s largest precision oncology initiative. Delivered by Omico and a national network of healthcare, research and industry partners, it provides eligible Australians with access to molecular profiling and matching to biomarker-led clinical trials and therapies (at no cost to the patient), while generating clinical, genomic, treatment and outcomes data to advance research, improve cancer care and inform future health policy.

Fortrea Contacts:
Galen Wilson (Media) – 703-298-0802, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com

Omico Contact:
Kym Bramich (Communications) – +61 414 795 087, k.bramich@omico.org.au

– Record of Over $300 Million of Investment Activity Completed and Under-Contract Year-to-Date –
– 2026 AFFO per Diluted Share Guidance Increased to $2.20 – $2.22 –

WINTER PARK, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial income properties, today announced its operating results and earnings for the three and nine months ended September 30, 2026.

Third Quarter 2026 Highlights

Operating results for the three and nine months ended September 30, 2026 and 2025 (dollars in thousands, except per share data):

                         
  Three Months Ended
September 30,
  Nine Months Ended
September 30,
    2026   2025     2026   2025  
Total Revenues   $ 20,460   $ 14,563     $ 58,868   $ 43,632  
Net Income (Loss) Attributable to Common Stockholders   $ 3,443   $ (1,310 )   $ 7,510   $ (4,130 )
Net Income (Loss) per Diluted Share Attributable to Common Stockholders   $ 0.18   $ (0.09 )   $ 0.42   $ (0.29 )
FFO Attributable to Common Stockholders (1)   $ 10,356   $ 7,135     $ 29,704   $ 20,832  
FFO Attributable to Common Stockholders per Diluted Share (1)   $ 0.55   $ 0.46     $ 1.65   $ 1.34  
AFFO Attributable to Common Stockholders (1)   $ 10,423   $ 7,128     $ 29,886   $ 20,909  
AFFO Attributable to Common Stockholders per Diluted Share (1)   $ 0.55   $ 0.46     $ 1.66   $ 1.34  

____________

(1)  See the “Non-GAAP Financial Measures” section and tables at the end of this press release for a discussion and reconciliation of Net Income (Loss) to non-GAAP financial measures.

“We continued to execute on our growth strategy in the third quarter, investing nearly $41 million at an attractive weighted average initial cash yield of 8.5%,” said John P. Albright, President and Chief Executive Officer of Alpine Income Property Trust. “Including our pending $117.3 million portfolio acquisition, our closed and under-contract investment activity year-to-date exceeds $300 million, a Company record that surpasses our full-year 2025 total of $278 million. Given this strong investment activity and the continued performance of our portfolio we are raising our full-year 2026 guidance.”

Investment Activity

Investments for the three and nine months ended September 30, 2026 (dollars in thousands):

                         
    Three Months Ended
September 30, 2026
  Nine Months Ended
September 30, 2026
    Number of
Investments
  Amount   Number of
Investments
  Amount
Properties (1)     3   $ 39,210       7   $ 85,785  
Commercial Loan Originations     1     1,720       5     105,650  
Total Investments     4   $ 40,930       12   $ 191,435  
                         
Properties – Weighted Average Initial Cash Cap Rate           8.5 %           8.0 %
Commercial Loans – Weighted Average Initial Coupon Rate (2)           10.0 %           13.0 %
Total Investments – Weighted Average Initial Yield           8.5 %           10.8 %
Properties – Weighted Average Remaining Lease Term at Time of Acquisition     4.3 years     13.4 years

____________

(1) The nine months ended September 30, 2026 investments include $26.3 million of property acquisitions that are accounted for as financing arrangements for GAAP purposes and are included in the Sale-Leaseback and Sales-Type Lease Properties, hereinafter defined.
(2) Includes paid-in-kind (“PIK”) interest coupon rate.

Pending Portfolio Acquisition and New Debt Financing

On October 9, 2026, the Company announced an agreement to acquire a 13-property industrial portfolio for $117.3 million, or $63 per square foot. The portfolio totals approximately 1.9 million square feet across 11 states and is 100% leased to nine tenants under absolute triple-net leases with annual rent escalations. The leases have a weighted average remaining lease term of 10.2 years, with no lease expirations before late 2031. The acquisition is expected to close in the fourth quarter of 2026, subject to customary closing conditions.

Subsequent to quarter end, the Company received bank commitments for a new $100 million four-year term loan and a $75 million increase in commitments under its revolving credit facility, to $325 million from $250 million. The new financing will increase the Company’s potential liquidity by $175 million, providing additional capacity to fund pending and future acquisitions.The new financing is expected to close in late October 2026, and the term loan proceeds will be used to repay outstanding revolving credit facility borrowings.

Disposition Activity

Dispositions for the three and nine months ended September 30, 2026 (dollars in thousands):

                         
    Three Months Ended
September 30, 2026
  Nine Months Ended
September 30, 2026
    Number of
Investments
  Amount   Number of
Investments
  Amount
Properties     —   $ —       3   $ 5,816  
Properties (Vacant)     1     410       1     410  
Commercial Loans     —     —       1     10,763  
Total Dispositions     1   $ 410       5   $ 16,989  
                         
Properties – Weighted Average Exit Cash Cap Rate           — %           7.4 %
Commercial Loans – Weighted Average Cash Yield           — %           10.0 %
Total Dispositions – Weighted Average Cash Yield           — %           9.1 %

Investments

The Company’s property and commercial loan portfolios consisted of the following as of September 30, 2026:

     
Property Portfolio    
Number of Properties   130  
Square Feet   4.8 million  
Annualized Base Rent (ABR) (1)   $53.9 million  
Weighted Average Remaining Lease Term   8.7 years  
States where Properties are Located   31  
Industries   25  
Occupancy   99.6 %
     
% of ABR Attributable to Investment Grade Rated Tenants   56 %
% of ABR Attributable to Credit Rated Tenants   68 %
% of ABR Attributable to Sale-Leaseback and Sales-Type Lease Properties (2)   12 %
     
Commercial Loan Portfolio (3)    
Number of Commercial Loans   11  
Outstanding Face Amount (4)   $160.1 million  
Weighted Average Coupon Rate (5)   13.4 %
Weighted Average Remaining Term   1.4 years  
Unfunded Commitment Amount   $75.5 million  

____________

(1) ABR represents annualized in-place straight-line base rent pursuant to GAAP. Annualized in-place cash base rent totaled $51.8 million.
(2) The Company owns four single-tenant income properties which were acquired through sale-leaseback transactions that include tenant repurchase options and one single-tenant income property which qualifies as a sales-type lease (collectively, the “Sale-Leaseback and Sales-Type Lease Properties”). These Sale-Leaseback and Sales-Type Lease Properties are accounted for as financing arrangements for GAAP purposes. However, as they constitute real estate assets for both legal and tax purposes, we include them for purposes of describing our property portfolio, including for tenant, industry, and state concentrations and exclude them for purposes of describing our commercial loan portfolio. The Sale-Leaseback and Sales-Type Lease Properties represent 10.0% of annualized in-place cash base rent.
(3) See Supplemental Disclosure on Commercial Loans and Investments on page 14 of this press release.
(4) Net of $18.5 million A-1 Participation and $57.2 million of financing related to Sale-Leaseback and Sales-Type Lease Properties.
(5) Includes PIK interest coupon rate.

The Company’s property portfolio included the following top tenants that represent 2.0% or greater of the Company’s total ABR as of September 30, 2026:

         
Tenant   Credit Rating   % of ABR
Lowe’s   BBB+ / Baa1   14 %
Dick’s Sporting Goods   BBB / Baa2   10 %
Beachside Hospitality Group   NR / NR   7 %
Walmart   AA / Aa2   6 %
Best Buy   BBB+ / A3   6 %
Alamo Drafthouse   A+ / A2   5 %
Dollar General   BBB / Baa3   4 %
Family Dollar   NR / NR   4 %
GermFree Laboratories   NR / NR   4 %
Walgreens   NR / NR   3 %
At Home   NR / NR   3 %
Bass Pro Shops   BB- / Ba3   3 %
BJ’s Wholesale Club   BB+ / Ba1   2 %
Academy Sports   BB+ / Ba2   2 %
Dollar Tree   BBB / Baa2   2 %
TJX Companies   A / A2   2 %
Aspen Retail   NR / NR   2 %
Other       21 %
Total       100 %

The Company’s property portfolio consisted of the following top industries that represent 2.0% or greater of the Company’s total ABR as of September 30, 2026:

     
Industry   % of ABR
Home Improvement   16 %
Sporting Goods   15 %
Casual Dining   10 %
Dollar Stores   10 %
Entertainment   7 %
Grocery   7 %
Consumer Electronics   6 %
Home Furnishings   6 %
Pharmacy   4 %
Off-Price Retail   4 %
Technology, Media & Life Sciences   4 %
Wholesale Club   2 %
Other   9 %
   Total   100 %

The Company’s property portfolio included properties in the following top states that represent 2.0% or greater of the Company’s total ABR as of September 30, 2026:

     
State   % of ABR
Florida   11 %
Texas   10 %
North Carolina   9 %
New Jersey   8 %
Colorado   7 %
Virginia   6 %
New York   6 %
Michigan   6 %
Illinois   5 %
Georgia   3 %
Ohio   3 %
Minnesota   3 %
West Virginia   3 %
Tennessee   3 %
Wisconsin   2 %
Kansas   2 %
Louisiana   2 %
Oklahoma   2 %
Other   9 %
   Total   100 %

Balance Sheet and Capital Markets

     
(Dollars in table in thousands) As of September 30, 2026
Leverage    
Net Debt / Total Enterprise Value   49.5 %
Net Debt / Pro Forma Adjusted EBITDA   6.5x  
Fixed Charge Coverage Ratio   3.1x  
     
Liquidity    
Available Capacity Under Revolving Credit Facility $ 51,500  
Cash and Cash Equivalents   11,722  
Total Liquidity $ 63,222  

As of September 30, 2026, the Company had $198.5 million outstanding under its Revolving Credit Facility, which had total commitments of $250.0 million. Borrowing availability under the Revolving Credit Facility is based on unencumbered asset value, as defined in the underlying credit agreement, and as of September 30, 2026, the Company had $51.5 million of additional borrowing availability. As discussed above, subsequent to quarter end, the Company received bank commitments for $175.0 million of new financing, consisting of a $100.0 million term loan and a $75.0 million increase in Revolving Credit Facility commitments, which is expected to close in late October 2026 and increases potential liquidity by $175.0 million.

During the three months ended September 30, 2026, the Company issued 335,457 common shares under its common stock ATM offering program at a weighted average gross price of $20.01 per share, for total net proceeds of $6.6 million. During the three months ended September 30, 2026, the Company issued 63,879 preferred shares under its Series A Preferred Stock ATM offering program at a weighted average gross price of $25.22 per share, for total net proceeds of $1.6 million.

During the nine months ended September 30, 2026, the Company issued 3,136,532 common shares under its common stock ATM offering program at a weighted average gross price of $19.38 per share, for total net proceeds of $59.9 million. During the nine months ended September 30, 2026, the Company issued 406,419 preferred shares under its Series A Preferred Stock ATM offering program at a weighted average gross price of $25.18 per share, for total net proceeds of $10.0 million.

The Company’s long-term debt as of September 30, 2026 (dollars in thousands):

                   
    As of September 30, 2026
    Face Value Debt   Stated Interest Rate   Wtd. Avg. Rate   Maturity Date
Revolving Credit Facility (1)   $ 198,500   SOFR +
[1.25% – 2.20%]
  4.96 %   February 2030
2029 Term Loan (2)     100,000   SOFR +
[1.25% – 1.90%]
  4.66 %   February 2029
2031 Term Loan (3)     100,000   SOFR +
[1.25% – 1.90%]
  3.35 %   February 2031
Total Debt/Weighted-Average Rate   $ 398,500       4.48 %    

____________

(1) As of September 30, 2026, the Company has utilized interest rate swaps to fix SOFR and achieve a weighted average fixed interest rate of 3.32% plus the applicable spread on $100 million of the outstanding balance on the Company’s Revolving Credit Facility.
(2) As of September 30, 2026, the Company has utilized interest rate swaps to fix SOFR and achieve a weighted average fixed interest rate of 3.36% plus the applicable spread for the $100 million 2029 Term Loan balance.
(3) As of September 30, 2026, the Company has utilized interest rate swaps to fix SOFR and achieve a weighted average fixed interest rate of 2.05% plus the applicable spread for the $100 million 2031 Term Loan balance.

As of September 30, 2026, the Company held a 93.6% common interest in Alpine Income Property OP, LP, the Company’s operating partnership (the “Operating Partnership” or “OP”). There were 1,223,854 common OP Units held by third parties outstanding and 17,935,407 shares of the Company’s common stock outstanding for a combined total of 19,159,261 shares of common stock and common OP Units held by third parties as of September 30, 2026. 

Dividends

The Company’s dividends for the three and nine months ended September 30, 2026:

           
  Three Months Ended
September 30, 2026
  Nine Months Ended
September 30, 2026
Preferred Dividends Declared and Paid per Share $ 0.500     $ 1.500  
Common Dividends Declared and Paid per Share $ 0.320     $ 0.920  
FFO Attributable to Common Stockholders Payout Ratio   58.2 %     55.8 %
AFFO Attributable to Common Stockholders Payout Ratio   58.2 %     55.4 %

2026 Outlook

The Company is revising its 2026 outlook. The Company’s 2026 guidance is based on current plans and a number of assumptions and is subject to risks and uncertainties, many of which are outside the Company’s control, and are more fully described in this press release and the Company’s reports filed with the U.S. Securities and Exchange Commission. Further, the Company’s 2026 outlook does not reflect the impact of any incentive management fee that may be due to our manager based on stockholder return for the calendar year.

The Company’s revised outlook for 2026 is as follows:

         
(Unaudited)   Prior 2026
Outlook (1)
  Revised 2026
Outlook
Net Income per Diluted Share   $0.81 to $0.84   $0.90 to $0.93
FFO Attributable to Common Stockholders per Diluted Share   $2.10 to $2.13   $2.19 to $2.21
AFFO Attributable to Common Stockholders per Diluted Share   $2.12 to $2.15   $2.20 to $2.22
Investment Volume   $170 to $200 Million   $310 to $350 Million
Disposition Volume   $20 to $40 Million   $20 to $40 Million

____________

(1) As issued on July 23, 2026.

Reconciliation of the outlook range of the Company’s 2026 estimated Net Income per Diluted Share to estimated FFO Attributable to Common Stockholders per Diluted Share, and AFFO Attributable to Common Stockholders per Diluted Share:

             
    Revised Outlook
Range for 2026
(Unaudited)   Low   High
Net Income per Diluted Share   $ 0.90     $ 0.93  
Depreciation and Amortization     1.59       1.58  
Provision for Impairment (1)     0.04       0.04  
Gain on Disposition of Assets (1)     (0.02 )     (0.02 )
FFO per Diluted Share   $ 2.51     $ 2.53  
Distributions to Preferred Stockholders     (0.32 )     (0.32 )
Funds From Operations Attributable to Common Stockholders per Diluted Share   $ 2.19     $ 2.21  
Amortization of Intangible Assets and Liabilities to Lease Income     (0.05 )     (0.06 )
Straight-Line Rent Adjustment     (0.04 )     (0.04 )
Non-Cash Compensation     0.02       0.02  
Amortization of Deferred Financing Costs to Interest Expense     0.06       0.06  
Other Non-Cash Adjustments     0.02       0.03  
AFFO Attributable to Common Stockholders per Diluted Share   $ 2.20     $ 2.22  

____________

(1) Provision for Impairment and Gain on Disposition of Assets represents the actual adjustment for the nine months ended September 30, 2026. The Company’s outlook excludes projections related to these measures.

Third Quarter 2026 Earnings Conference Call & Webcast

The Company will host a conference call to present its operating results for the three and nine months ended September 30, 2026, on Friday, October 23, 2026 at 9:00 AM ET.

A live webcast of the call will be available on the Investor Relations page of the Company’s website at www.alpinereit.com or at the link provided in the event details below. To access the call by phone, please go to the link provided in the event details below and you will be provided with dial-in details.

  Webcast: https://edge.media-server.com/mmc/p/gx2epmx6
  Dial-In:  https://register-conf.media-server.com/register/BIdda2983b5d4a42ac87f47a22c6553594

We encourage participants to dial into the conference call at least fifteen minutes ahead of the scheduled start time. A replay of the earnings call will be archived and available online through the Investor Relations section of the Company’s website at www.alpinereit.com.

About Alpine Income Property Trust, Inc.

Alpine Income Property Trust, Inc. (NYSE: PINE) is a publicly traded real estate investment trust that seeks to deliver attractive risk-adjusted returns and dependable cash dividends by investing in, owning and operating a portfolio of single tenant net leased commercial income properties that are predominately leased to high-quality publicly traded and credit-rated tenants. The Company also complements its income property portfolio by strategically investing in a select portfolio of commercial loan investments intended to deliver an attractive risk-adjusted return.

We encourage you to review our most recent investor presentation which is available on our website at http://www.alpinereit.com.

Safe Harbor

This press release may contain “forward-looking statements.” Forward-looking statements include statements that may be identified by words such as “outlook,” “could,” “may,” “might,” “will,” “likely,” “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects,” “continues,” “projects” and similar references to future periods, or by the inclusion of forecasts or projections. Forward-looking statements are based on the Company’s current expectations and assumptions regarding capital market conditions, the Company’s business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include general business and economic conditions, continued volatility and uncertainty in the credit markets and broader financial markets, geopolitical conflicts, tariffs and international trade policies, risks inherent in the real estate business, including tenant or borrower defaults, potential liability relating to environmental matters, credit risk associated with the Company investing in commercial loans and investments, illiquidity of real estate investments and potential damages from natural disasters, the impact of epidemics or pandemics on the Company’s business and the businesses of its tenants and borrowers and the impact of such epidemics or pandemics on the U.S. economy and market conditions generally, other factors affecting the Company’s business or the businesses of its tenants and borrowers that are beyond the control of the Company or its tenants or borrowers, and the factors set forth under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and other risks and uncertainties discussed from time to time in the Company’s filings with the U.S. Securities and Exchange Commission. Any forward-looking statement made in this press release speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. 

Non-GAAP Financial Measures

Our reported results are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). We also disclose Funds From Operations (“FFO”), Adjusted Funds From Operations (“AFFO”), and Pro Forma Earnings Before Interest, Taxes, Depreciation and Amortization (“Pro Forma Adjusted EBITDA”), all of which are non-GAAP financial measures. We believe these non-GAAP financial measures are useful to investors because they are widely accepted industry measures used by analysts and investors to compare the operating performance of REITs. 

FFO, AFFO, and Pro Forma Adjusted EBITDA do not represent cash generated from operating activities and are not necessarily indicative of cash available to fund cash requirements; accordingly, they should not be considered alternatives to net income or loss as a performance measure or cash flows from operations as reported on our statement of cash flows as a liquidity measure and should be considered in addition to, and not in lieu of, GAAP financial measures. 

We compute FFO in accordance with the definition adopted by the Board of Governors of the National Association of Real Estate Investment Trusts, or NAREIT. NAREIT defines FFO as GAAP net income or loss adjusted to exclude real estate related depreciation and amortization, as well as extraordinary items (as defined by GAAP) such as net gain or loss from sales of depreciable real estate assets, impairment write-downs associated with depreciable real estate assets and impairments associated with the implementation of current expected credit losses on commercial loans and investments at the time of origination, including the pro rata share of such adjustments of unconsolidated subsidiaries. The Company also excludes the gains or losses from sales of assets incidental to the primary business of the REIT which specifically include the sales of investment securities, if any, in addition to the mark-to-market of the Company’s investment securities.

To derive AFFO, we further modify the NAREIT computation of FFO to include other adjustments to GAAP net income related to non-cash revenues and expenses such as loss on extinguishment of debt, amortization of above- and below-market lease related intangibles, straight-line rental revenue, amortization of deferred financing costs, non-cash compensation, and other non-cash adjustments to income or expense. Such items may cause short-term fluctuations in net income or loss but have no impact on operating cash flows or long-term operating performance. We use AFFO as one measure of our performance when we formulate corporate goals. 

To derive Pro Forma Adjusted EBITDA, GAAP net income or loss is adjusted to exclude extraordinary items (as defined by GAAP), net gain or loss from sales of depreciable real estate assets, impairment write-downs associated with depreciable real estate assets and impairments associated with the implementation of current expected credit losses on commercial loans and investments at the time of origination and/or payoff, and real estate related depreciation and amortization including the pro rata share of such adjustments of unconsolidated subsidiaries, non-cash revenues and expenses such as straight-line rental revenue, amortization of deferred financing costs, loss on extinguishment of debt, above- and below-market lease related intangibles, non-cash compensation, other non-cash income or expense, and other non-recurring items such as disposition management fees and commission fees. The Company also excludes the gains or losses from sales of assets incidental to the primary business of the REIT which specifically include the sales of investment securities, if any, in addition to the mark-to-market of the Company’s investment securities. Cash interest expense is also excluded from Pro Forma Adjusted EBITDA, and GAAP net income or loss is adjusted for the annualized impact of acquisitions, dispositions and other similar activities.

FFO is used by management, investors and analysts to facilitate meaningful comparisons of operating performance between periods and among our peers primarily because it excludes the effect of real estate depreciation and amortization and net gains or losses on sales, which are based on historical costs and implicitly assume that the value of real estate diminishes predictably over time, rather than fluctuating based on existing market conditions. We believe that AFFO is an additional useful supplemental measure for investors to consider because it will help them to better assess our operating performance without the distortions created by other non-cash revenues or expenses. We also believe that Pro Forma Adjusted EBITDA is an additional useful supplemental measure for investors to consider as it allows for a better assessment of our operating performance without the distortions created by other non-cash revenues, expenses or certain effects of the Company’s capital structure on our operating performance. FFO, AFFO, and Pro Forma Adjusted EBITDA may not be comparable to similarly titled measures employed by other companies.

GAAP requires that the Sale-Leaseback and Sales-Type Lease Properties and the value of participation obligation interests sold (the “Participation Obligations Sold”) for which sale accounting was not achieved be accounted for as financing arrangements. Accordingly, for GAAP purposes, the Sale-Leaseback and Sales-Type Lease Properties and Participation Obligations Sold are included in the Company’s Commercial Loans and Investments segment. However, for statistical purposes, the Company excludes the Sale-Leaseback and Sales-Type Lease Properties and the Participation Obligations Sold. Please see page 14 of this press release for further details. We believe that the Supplemental Disclosure on Commercial Loans and Investments is an additional useful measure for investors to consider because it will help them to better assess the performance of our Commercial Loan Portfolio.

Other Definitions

Annualized Base Rent (ABR) represents the annualized in-place straight-line base rent pursuant to GAAP.

Annualized In-Place Cash Base Rent represents the annualized in-place contractual minimum base rent on a cash basis.

Credit Rated Tenant is a tenant or the parent of a tenant with a credit rating from S&P Global Ratings, Moody’s Investors Service, Fitch Ratings or the National Association of Insurance Commissioners.

Investment Grade Rated Tenant is a tenant or the parent of a tenant with a credit rating from S&P Global Ratings, Moody’s Investors Service, Fitch Ratings or the National Association of Insurance Commissioners of Baa3, BBB-, or NAIC-2 or higher. If applicable, in the event of a split rating between S&P Global Ratings and Moody’s Investors Services, the Company utilizes the higher of the two ratings as its reference point as to whether a tenant is defined as an Investment Grade Rated Tenant. Credit ratings utilized in this press release are those available from S&P Global Ratings and/or Moody’s Investors Service, as applicable, as of September 30, 2026.

Weighted Average Remaining Lease Term is weighted by the ABR and does not assume the exercise of any tenant purchase options.

Alpine Income Property Trust, Inc.
Consolidated Balance Sheets
(In thousands, except share and per share data)

           
  As of
  (Unaudited) September 30, 2026   December 31, 2025
ASSETS      
Real Estate:          
Land, at Cost $ 175,167     $ 151,628  
Building and Improvements, at Cost   373,114       344,138  
Total Real Estate, at Cost   548,281       495,766  
Less, Accumulated Depreciation   (66,967 )     (54,446 )
Real Estate—Net   481,314       441,320  
Assets Held for Sale   966       8,077  
Commercial Loans and Investments   231,421       167,553  
Cash and Cash Equivalents   11,722       4,589  
Restricted Cash   19,139       34,410  
Intangible Lease Assets—Net   47,888       48,925  
Straight-Line Rent Adjustment   2,597       2,092  
Other Assets   26,059       8,908  
Total Assets $ 821,106     $ 715,874  
LIABILITIES AND EQUITY          
Liabilities:          
Accounts Payable, Accrued Expenses, and Other Liabilities $ 16,647     $ 7,877  
Prepaid Rent and Deferred Revenue   14,286       14,031  
Intangible Lease Liabilities—Net   6,120       4,971  
Obligation Under Participation Agreement   18,519       10,000  
Long-Term Debt—Net   396,676       377,739  
Total Liabilities   452,248       414,618  
Commitments and Contingencies          
Equity:          
Preferred Stock, 100 million shares authorized, $0.01 par value per share, 8.00% Series A Cumulative Redeemable Preferred Stock, $25.00 Per Share Liquidation Preference, 2,489,747 shares issued and outstanding as of September 30, 2026 and 2,083,328 shares issued and outstanding as of December 31, 2025   25       21  
Common Stock, $0.01 par value per share, 500 million shares authorized, 17,935,407 shares issued and outstanding as of September 30, 2026 and 14,783,419 shares issued and outstanding as of December 31, 2025   179       148  
Additional Paid-in Capital   383,408       313,690  
Dividends in Excess of Net Income   (43,689 )     (35,276 )
Accumulated Other Comprehensive Income   7,452       1,293  
Stockholders’ Equity   347,375       279,876  
Noncontrolling Interest   21,483       21,380  
Total Equity   368,858       301,256  
Total Liabilities and Equity $ 821,106     $ 715,874  


Alpine Income Property Trust, Inc.
Consolidated Statements of Operations
(Unaudited)
(In thousands, except share, per share and dividend data)

                         
    Three Months Ended
September 30,
  Nine Months Ended
September 30,
    2026   2025   2026   2025
Revenues:                        
Lease Income   $ 12,812     $ 12,122     $ 38,051     $ 35,970  
Interest Income from Commercial Loans and Investments     7,611       2,320       20,700       7,358  
Other Revenue     37       121       117       304  
Total Revenues     20,460       14,563       58,868       43,632  
Operating Expenses:                        
Real Estate Expenses     2,095       1,891       6,482       6,030  
General and Administrative Expenses     2,009       1,695       5,896       5,108  
Provision for Impairment and Adjustment to CECL Reserve     (76 )     1,915       809       6,749  
Depreciation and Amortization     6,881       6,597       20,901       20,609  
Total Operating Expenses     10,909       12,098       34,088       38,496  
Gain (Loss) on Disposition of Assets     272       (46 )     369       2,043  
Net Income From Operations     9,823       2,419       25,149       7,179  
Investment and Other Income     17       68       472       160  
Interest Expense     (4,828 )     (3,910 )     (13,760 )     (11,822 )
Net Income (Loss)     5,012       (1,423 )     11,861       (4,483 )
Less: Net Loss (Income) Attributable to Noncontrolling Interest     (324 )     113       (797 )     353  
Net Income (Loss) Attributable to Alpine Income Property Trust, Inc.     4,688       (1,310 )     11,064       (4,130 )
Less: Distributions to Preferred Stockholders     (1,245 )     —       (3,554 )     —  
Net Income (Loss) Attributable to Common Stockholders   $ 3,443     $ (1,310 )   $ 7,510     $ (4,130 )
                         
Per Common Share Data:                        
Net Income (Loss) Attributable to Common Stockholders                        
Basic   $ 0.19     $ (0.09 )   $ 0.45     $ (0.29 )
Diluted   $ 0.18     $ (0.09 )   $ 0.42     $ (0.29 )
                         
Weighted Average Number of Common Shares:                        
Basic     17,694,160       14,158,190       16,776,481       14,328,245  
Diluted (1)     18,918,014       15,382,044       18,000,335       15,552,099  
                         
Dividends Declared and Paid – Preferred Stock   $ 0.500     $ —     $ 1.500     $ —  
Dividends Declared and Paid – Common Stock   $ 0.320     $ 0.285     $ 0.920     $ 0.855  

____________

(1)  Includes 1,223,854 shares during the three and nine months ended September 30, 2026 and 2025, underlying 1,223,854 OP Units issued to CTO Realty Growth, Inc. and its wholly owned subsidiaries.

        

Alpine Income Property Trust, Inc.
Non-GAAP Financial Measures
Funds From Operations and Adjusted Funds From Operations
(Unaudited)
(In thousands, except per share data)

                         
    Three Months Ended
September 30,
  Nine Months Ended
September 30,
    2026   2025   2026   2025
Net Income (Loss)   $ 5,012     $ (1,423 )   $ 11,861     $ (4,483 )
Depreciation and Amortization     6,881       6,597       20,901       20,609  
Provision for Impairment and Adjustment to CECL Reserve     (76 )     1,915       809       6,749  
Loss (Gain) on Disposition of Assets     (272 )     46       (369 )     (2,043 )
Unrealized Loss on Investment Securities     56       —       56       —  
Funds From Operations   $ 11,601     $ 7,135     $ 33,258     $ 20,832  
Distributions to Preferred Stockholders     (1,245 )     —       (3,554 )     —  
Funds From Operations Attributable to Common Stockholders   $ 10,356     $ 7,135     $ 29,704     $ 20,832  
Adjustments:                        
Amortization of Intangible Assets and Liabilities to Lease Income     (256 )     (176 )     (733 )     (422 )
Straight-Line Rent Adjustment     (191 )     (177 )     (508 )     (539 )
Non-Cash Compensation     95       95       285       285  
Amortization of Deferred Financing Costs to Interest Expense     303       197       871       591  
Other Non-Cash Adjustments     116       54       267       162  
Adjusted Funds From Operations Attributable to Common Stockholders   $ 10,423     $ 7,128     $ 29,886     $ 20,909  
                         
FFO Attributable to Common Stockholders per Diluted Share   $ 0.55     $ 0.46     $ 1.65     $ 1.34  
AFFO Attributable to Common Stockholders per Diluted Share   $ 0.55     $ 0.46     $ 1.66     $ 1.34  
                         
Supplemental Disclosure:                        
PIK Interest Earned   $ 900     $ —     $ 2,373     $ —  
PIK Interest Paid     —       —       50       —  
PIK Interest Earned in Excess of PIK Interest Paid   $ 900     $ —     $ 2,323     $ —  


Alpine Income Property Trust, Inc.
Non-GAAP Financial Measures
Reconciliation of Net Debt to Pro Forma Adjusted EBITDA
(Unaudited)
(In thousands)

       
    Three Months Ended September 30, 2026
Net Income   $ 5,012  
Adjustments:      
Depreciation and Amortization     6,881  
Provision for Impairment and Adjustment to CECL Reserve     (76 )
Gain on Disposition of Assets     (272 )
Unrealized Loss on Investment Securities     56  
Distributions to Preferred Stockholders     (1,245 )
Amortization of Intangible Assets and Liabilities to Lease Income     (256 )
Straight-Line Rent Adjustment     (191 )
Non-Cash Compensation     95  
Amortization of Deferred Financing Costs to Interest Expense     303  
Other Non-Cash Adjustments     116  
Other Non-Recurring Items     (22 )
Interest Expense, Net of Deferred Financing Costs Amortization and Interest on Obligation Under Participation Agreement     4,044  
Adjusted EBITDA   $ 14,445  
       
Annualized Adjusted EBITDA   $ 57,780  
Pro Forma Annualized Impact of Current Quarter Investment Activity (1)     1,598  
Pro Forma Adjusted EBITDA   $ 59,378  
       
Total Long-Term Debt   $ 396,676  
Financing Costs, Net of Accumulated Amortization     1,824  
Cash and Cash Equivalents     (11,722 )
Net Debt   $ 386,778  
Net Debt to Pro Forma Adjusted EBITDA     6.5x

____________

(1) Reflects the pro forma annualized impact on Annualized Adjusted EBITDA of the Company’s investment and disposition activity during the three months ended September 30, 2026.

Alpine Income Property Trust, Inc.
Non-GAAP Financial Measures
Supplemental Disclosure on Commercial Loans and Investments
(Unaudited)
(In thousands)

                                 
    As of and for the Nine Months Ended September 30, 2026
    Commercial Loan Portfolio   Plus: Participation Obligations Sold   Total Commercial Loans   Plus: Sale-Leaseback and Sale-Type Lease Transactions   Commercial Loans and Investments Pursuant to GAAP  
Face Amount, Beginning of Period   $ 129,813     $ 10,000     $ 139,813     $ 31,133     $ 170,946    
Draws (Including Accrued PIK Interest)     63,828       10,763       74,591       26,257       100,848    
Principal Repayments     (33,536 )     (2,244 )     (35,780 )     (234 )     (36,014 )  
Face Amount, End of Period     160,105       18,519       178,624       57,156       235,780    
Unaccreted Origination Fees     (2,001 )     —       (2,001 )     —       (2,001 )  
CECL Reserve     (1,601 )     (185 )     (1,786 )     (572 )     (2,358 )  
Carrying Amount, End of Period   $ 156,503     $ 18,334     $ 174,837     $ 56,584     $ 231,421    
                                 
Cash Interest Income   $ 12,747     $ 1,301     $ 14,048     $ 3,226     $ 17,274    
PIK Interest Earned     2,373       —       2,373       —       2,373    
Accretion of Commercial Loans and Investments Origination Fees     1,053       —       1,053       —       1,053    
Total Interest Income   $ 16,173     $ 1,301     $ 17,474     $ 3,226     $ 20,700    
                                 
Weighted Average Coupon Rate, End of Period (1)     13.4   %   10.0   %   13.0   %   8.3   %   11.9   %

____________

(1) Includes PIK interest coupon rate.

CONTACT: Contact:        
Investor Relations
ir@alpinereit.com

Clinical development of ARD-101 for hyperphagia in Prader-Willi Syndrome (PWS) may resume

Aardvark will host a webcast to review available dataset from the terminated Phase 3 HERO trial and OLE trial on Friday, October 23, 2026, at 8:00 a.m. EST

SAN DIEGO, Oct. 22, 2026 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark or the Company) (Nasdaq: AARD), a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics designed to suppress hunger for the treatment of Prader-Willi Syndrome (PWS) and metabolic diseases, today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Company’s Investigational New Drug application for ARD-101 for the treatment of hyperphagia in PWS.

“We are pleased that the FDA has lifted the clinical hold on ARD-101, allowing us to continue advancing our clinical development program,” said Tien Lee, M.D., Founder and Chief Executive Officer of Aardvark. “With strong alignment and collaboration with the FDA, we completed the work necessary to allow for the resumption of clinical studies. People living with PWS and their families continue to face profound unmet need, and we look forward to working with the FDA as we advance ARD-101.”

On February 27, 2026, Aardvark voluntarily paused dosing in the Phase 3 Hunger Elimination or Reduction Objective (HERO) trial and its open-label extension (OLE) trial following reversible electrocardiogram (ECG) changes observed during routine safety monitoring in a separate study in healthy volunteers. In May 2026, the FDA placed a clinical hold on the HERO trial and OLE trial. In alignment with the FDA, the Company conducted a thorough ECG study in additional healthy volunteers and an in vitro cardiac sodium channel (NaV1.5) study. No cardiac events were observed in the recently completed ECG study at ARD-101 doses of 200 mg and 400 mg twice daily.

Aardvark plans to resume clinical development of ARD-101 in patients with PWS following additional anticipated engagement and alignment with the FDA on the Phase 3 trial design. As previously announced, Aardvark unblinded the data accumulated across both the HERO trial and OLE trial to assess the totality of available efficacy and safety data.

Conference Call and Webcast

The Company will host a live conference call and webcast for investors to discuss data from the terminated HERO and OLE trials tomorrow, October 23, 2026, at 8:00 AM ET. To access the live conference call, participants may register here. To access the live webcast and subsequent archived recording of this event, please visit the Investors section of Aardvark’s website.

About ARD-101

ARD-101 is an oral, small-molecule therapeutic designed to stimulate the release of gut-peptide hormones through activation of bitter taste receptors. ARD-101 is being developed as a treatment for hyperphagia associated with Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable hunger.

About Aardvark Therapeutics, Inc.

Aardvark is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics designed to suppress hunger for the treatment of Prader-Willi Syndrome (PWS) and metabolic diseases. Hunger, which is the discomfort from not having eaten recently, is a distinct neural signaling pathway separate from appetite, the reward-seeking desire for food. Our programs explore therapeutic applications in hunger-associated indications and potential complementary uses with anti-appetite therapies. For more information, visit www.aardvarktherapeutics.com.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements.” These statements include, but are not limited to, statements concerning: Aardvark’s business strategy, product candidates, the path forward for ARD-101, including the anticipated resumption of the clinical development of ARD-101 and any further engagement and alignment with the FDA prior to such resumption, as well as plans and objectives of management for future operations. The words, without limitation, “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the risk that the FDA may not agree with Aardvark’s proposed Phase 3 program or may require additional studies; limitations in interpreting data from the HERO trial and its OLE trial, which were terminated early and were not powered to assess efficacy; the risk of unfavorable clinical trial results; the risk that results from earlier clinical trials and preclinical studies may not necessarily be predictive of future results; the risk that Aardvark may use its capital resources sooner than expected; and other risks and uncertainties, including the factors described under the “Risk Factors” section of Aardvark’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the Securities and Exchange Commission on August 11, 2026. When evaluating Aardvark’s business and prospects, careful consideration should be given to these risks and uncertainties. Any forward-looking statements contained in this press release are based on the current expectations of Aardvark’s management team and speak only as of the date hereof, and Aardvark specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

Investor and Media Contact
Argot Partners
(212) 600-1902
Aardvark@Argotpartners.com 

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.